- Tytuł :
- Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial
- Autorzy :
- Temat :
-
General Biochemistry ,Genetics andMolecular Biology General Medicine
Dermatology Clinic
610 Medicine & healthGeneral Biochemistry ,Genetics andMolecular Biology ,General Medicine - Źródło :
- Dummer, R; Gyorki, D E; Hyngstrom, J; Berger, A C; Conry, R; Demidov, L; Sharma, A; Treichel, S A; Radcliffe, H; Gorski, K S; Anderson, A; Chan, E; Faries, M; Ross, M I (2021). Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial. Nature Medicine, 27(10):1789-1796.
- Opis pliku :
- application/pdf
- Dostępność :
-
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a43b3fbc2256dc5161d01215a49992b
https://www.nature.com/articles/s41591-021-01510-7.pdf